Inflammatory Mediator Profiling Reveals Immune Properties of Chemotactic Gradients and Macrophage Mediator Production Inhibition during Thioglycollate Elicited Peritoneal Inflammation
Figure 1
Fold increases of total cell numbers in peritoneal exudate during thioglycollate treatment in vivo. C57BL/6 mice (males) were treated with thioglycollate as described in Section 2. At three timepoints, before (day 0) and after (day 1 and 3) the treatment, peritoneal exudate cells were isolated and counted as described in Section 2. Fold increases were calculated as the cell number at a timepoint divided by the cell number on day 0 (defined as 1). Values are presented as the means ± SE. -4 per timepoint. * versus day 0.
